Drug recall · April 6, 2022
Lansoprazole Delayed-Release Capsules recall
Why: Failed Dissolution Specifications; during long term stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India
- Lots / codes
Lot # a) C2103093, Exp. 12/2023; b)C2103092, Exp. 12/2023.
- Quantity
- 8,352 bottles (30-count), 1,368 bottles (90-count)
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 23, 2022 · Voluntary: Firm initiated
- Classified
- March 31, 2022
- Reported
- April 6, 2022
- Ended
- February 2, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lansoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.